Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture.
about
Repurposing of approved cardiovascular drugsBeta3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES).Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight.Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formationBeta-1 adrenergic agonist treatment mitigates negative changes in cancellous bone microarchitecture and inhibits osteocyte apoptosis during disuse.Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in miceAntihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis.Neuronal regulation of bone metabolism and anabolism: calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone.Six months of disuse during hibernation does not increase intracortical porosity or decrease cortical bone geometry, strength, or mineralization in black bear (Ursus americanus) femurs.Gs G protein-coupled receptor signaling in osteoblasts elicits age-dependent effects on bone formation.Emerging neuroskeletal signalling pathways: a review.Bone and brain: a review of neural, hormonal, and musculoskeletal connections.Antihypertensive Medications and the Survival Rate of Osseointegrated Dental Implants: A Cohort Study.Emerging and potential therapies for osteoporosis.The role of the sympathetic nervous system in controlling bone metabolism.Relationship of sympathetic activity to bone microstructure, turnover, and plasma osteopontin levels in women.A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms.Spinal and paraspinal lesions: the role of stereotactic body radiotherapy.Emerging pharmacologic therapies for osteoporosis.Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy.Control of bone remodeling by the peripheral sympathetic nervous systemDoping and musculoskeletal system: short-term and long-lasting effects of doping agents.Heart failure as a risk factor for osteoporosis and fractures.The Vestibular System: A Newly Identified Regulator of Bone Homeostasis Acting Through the Sympathetic Nervous System.β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.Sympathetic denervation-induced MSC mobilization in distraction osteogenesis associates with inhibition of MSC migration and osteogenesis by norepinephrine/adrb3.The skeleton and the sympathetic nervous system: it's about time!Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes.In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria.Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression.Neuronal Control of Bone Remodeling.Adrenaline inhibits osteogenesis via repressing miR-21 expression.Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.Doping dose of salbutamol and exercise training: impact on the skeleton of ovariectomized rats.Beta-blocker and other analogous treatments that affect bone mass and sympathetic nerve activity in ovariectomized rats.Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.Outcome of enamel matrix derivative treatment in the presence of chronic stress: histometric study in rats.Continuous treatment with a low-dose β-agonist reduces bone mass by increasing bone resorption without suppressing bone formation.Propranolol enhances bone healing and implant osseointegration in rats tibiae.β-blockers reduce bone resorption marker in early postmenopausal women
P2860
Q28074453-2E7138AB-2F49-490A-B523-1B6C909195A8Q33248818-D46A6F39-5ABB-4A00-9CB7-0A777A74E039Q33520220-77E62C92-DABD-4729-A7A8-EEC88BE907F2Q33735917-87E0AD0E-3D71-4B97-B005-DA45CDB0D56DQ34166085-78BD7D85-D79E-4198-AD7D-91997E577C1CQ34344554-BE282FF2-7122-4159-A461-46B9FFBB968EQ34402961-64AEF772-47E8-46F2-94AA-EDCEBA7EC8F8Q34803962-53AFE06F-BEE9-4E36-A000-0375FA052E96Q34981618-38C822AB-99C9-4F38-9BBB-7A4BBA8B559CQ35156288-6F983D0F-F6BB-48D3-BE77-9316C29D8021Q35666132-DD5F1364-6FB9-44A2-B8C5-D538C8C6CA5DQ35836467-5F82B6D1-4D88-4906-BF3D-AC93FBC46BAEQ35943604-69D075AE-A2CB-404D-BE04-45F3B77D5157Q36099415-0AA76694-934E-4641-A213-6D7CF68FE14CQ36268296-1C444A30-93B5-4F6C-B5D7-8BEE247053FCQ36361444-42D7649F-7327-4B30-907C-015D12E70801Q36886615-B133248A-B80A-4ECD-8425-4047EB18CA94Q36887077-219A5986-BB1A-4DD0-83DD-8B95EAEF3D50Q36944034-F475E165-B1DE-4676-9958-BB71B53FA416Q37072802-1E3A9E0C-6206-480B-A694-A5D19EAE1811Q37445916-38D76895-CE7D-4F7D-BCBF-CEC40EB7C441Q37805634-C037985B-091E-40EF-8C08-D5900F8ED2D8Q38036949-9062E678-0E9A-451F-907F-980A254C9D73Q38504769-2D89CDBE-8220-46CA-B257-2FD44B495009Q39241378-01403544-8565-44AF-A88F-19B47CB661D2Q42103326-C76F0632-315C-4F45-9ED0-BB5D64EFDC91Q42387414-A3488E86-ADE7-41CF-B840-16044BB1F001Q44047436-9E01BBC4-5993-4C89-A54E-F948CC28D518Q44538194-DDCD8A1F-D162-4C0F-AB8C-D8D6FFF6B254Q46279970-9F8C8325-D45A-4A37-B1CF-F3229C34A2DEQ47981326-CB227890-62C3-4CA5-A55B-D87473E56BAFQ50228153-862D7768-E936-456A-8BBB-E9F0F529193BQ51420122-CFFAD346-3DF5-4EAA-8E78-42214F5EA6ACQ51754302-A2061839-522B-4136-A37F-C440F057D7DDQ51768665-C310A5A8-B9A5-489F-812D-05028185813CQ52758855-03427DDE-FC55-4F7F-8F18-2C83606FF566Q53081268-5DBC9644-F88F-48F0-BF45-069E743D5C8DQ53753971-3D3CF75B-4321-466A-AD71-5197916CCBB1Q53841928-473FA130-22E2-415D-8880-6AB20662862DQ57533556-33C33E10-805E-4E3F-A211-035C004E3B47
P2860
Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Characterization of beta-adren ...... e resorption in organ culture.
@en
type
label
Characterization of beta-adren ...... e resorption in organ culture.
@en
prefLabel
Characterization of beta-adren ...... e resorption in organ culture.
@en
P2093
P1433
P1476
Characterization of beta-adren ...... e resorption in organ culture.
@en
P2093
Smith CK 2nd
Tashjian AH Jr
Voelkel EF
P304
P356
10.1016/S0169-6009(08)80105-5
P577
1993-12-01T00:00:00Z